Myelodysplastic syndromes - D46
Use Additional Code: This note indicates that an additional code should be used in conjunction with the primary code "D46" to provide a complete picture of the patient's condition or to capture associated factors.
Use Additional:
- code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
Excludes2: This note means that the conditions described by two codes are not usually associated with each other but can sometimes occur together.
Type 2 Excludes:
- drug-induced aplastic anemia (D61.1)
These ranges represents subcategories of Myelodysplastic syndromes. The "D46" signifies that these are the diseases within this broad category.
Codes:
- D46.0 - Refractory anemia without ring sideroblasts, so stated
- D46.1 - Refractory anemia with ring sideroblasts
- D46.2 - Refractory anemia with excess of blasts [RAEB]
- D46.20 - Refractory anemia with excess of blasts, unspecified
- D46.21 - Refractory anemia with excess of blasts 1
- D46.22 - Refractory anemia with excess of blasts 2
- D46.4 - Refractory anemia, unspecified
- D46.9 - Myelodysplastic syndrome, unspecified
- D46.A - Refractory cytopenia with multilineage dysplasia
- D46.B - Refractory cytopenia with multilineage dysplasia and ring sideroblasts
- D46.C - Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality
- D46.Z - Other myelodysplastic syndromes